WuXi PharmaTech (Cayman) Inc. (ADR) 

(Public, NYSE:WX)   Watch this stock   
Find more results for wx
Nov 17, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 16, 2009
Q3 2009 Earnings Release
Sep 17, 2009
Bank of America/Merrill Lynch Global Healthcare Conference
Sep 15, 2009
Morgan Stanley Global Healthcare Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q2 (Jun '09) 2008
Net profit margin 21.93% -5.90%
Operating margin 20.37% -8.26%
EBITD margin - 3.99%
Return on average assets 15.32% -4.40%
Return on average equity 23.96% -6.20%
Employees 3,773 -

Address

288 Fute Zhong Road Waigaoqiao Free Trade Zone
Shanghai, SHA 200131
China
+86-21-50461111 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

WuXi PharmaTech (Cayman) Inc. (ADR) discussions

  View all discussions »

Description

WuXi PharmaTech (Cayman) Inc. (WuXi) is a pharmaceutical, biotechnology and medical device research and development (R&D) outsourcing company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the R&D process to its customers, which include pharmaceutical, biotechnology and medical device companies. The Company operates in two segments: laboratory services and manufacturing. Laboratory services for pharmaceutical, biotechnology and medical device companies. Manufacturing segment services for producing advanced intermediates and active pharmaceutical ingredients for use by pharmaceutical companies in preclinical and clinical trials. In January 2008, the Company completed its acquisition of AppTec Laboratory Services, Inc.

Officers and directors

Ge Li Ph.D.
Chairman of the Board, Chief Executive Officer, Founder
Age: 42
Bio & Compensation - Reuters
Edward Hu
Acting Chief Financial Officer, Chief Operating Officer
Age: 46
Bio & Compensation - Reuters
Xiaozhong Liu
Executive Vice President, Director, Founder
Age: 45
Bio & Compensation - Reuters
Richard M. Soll
Senior Vice President - Integrated Services
Bio & Compensation - Reuters
Hao Zhou
Vice President - Finance
Age: 33
Bio & Compensation - Reuters
Zhaohui Zhang
Vice President - Domestic Marketing, Director, Founder
Age: 39
Bio & Compensation - Reuters
Bob Zhu
Vice President - Human Resources and Corporate Communications
Age: 40
Bio & Compensation - Reuters
Chi-Chung Chan
Vice President - Pharmacology
Bio & Compensation - Reuters
Hui Cai
Vice President - Business Development
Bio & Compensation - Reuters
Shuhui Chen Ph.D.
Chief Scientific Officer
Age: 45
Bio & Compensation - Reuters